Raffaele Ratta

Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study

Toni K. Choueiri, Laurence Albigès, Philippe Barthélémy et al. · The Lancet · 2024 · 54 citations · Full text

Urology, Genitourinary Cancer, Medicine +8

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study

Giuseppe Procopio, Giulia Apollonio, Francesco Cognetti et al. · European Urology Oncology · 2019 · 52 citations

Urology, Surgical Oncology, Genitourinary Cancer +5

KEYNOTE-921: Phase III Study of Pembrolizumab Plus Docetaxel for Metastatic Castration-Resistant Prostate Cancer

Daniel P. Petrylak, Raffaele Ratta, Rustem Gafanov et al. · Future Oncology · 2021 · 48 citations · Full text

Influenza Vaccine Indication During Therapy with Immune Checkpoint Inhibitors: A Transversal Challenge. The Invidia Study

Melissa Bersanelli, Diana Giannarelli, Paola Castrignanò et al. · Immunotherapy · 2018 · 46 citations · Full text

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression

Vera Cappelletti, Elena Verzoni, Raffaele Ratta et al. · International Journal of Molecular Sciences · 2020 · 45 citations · Full text

Pathology, Tumor Biology, Ctc Types +20